PIUR IMAGING GmbH: Comprehensive Company Profile

Background

Company Overview

Founded in 2014 and headquartered in Vienna, Austria, PIUR IMAGING GmbH specializes in AI-driven tomographic 3D ultrasound solutions. The company's mission is to enhance access to safe, accurate, and non-invasive diagnostic imaging by transforming standard 2D ultrasound systems into advanced 3D imaging devices. This innovation aims to bridge the gap between traditional ultrasound and more complex imaging modalities like CT and MRI, thereby improving diagnostic workflows and patient outcomes.

Key Strategic Focus

Core Objectives and Specialization

PIUR IMAGING focuses on developing vendor-independent tomographic 3D ultrasound solutions that integrate seamlessly with existing ultrasound equipment. Their flagship product, PIUR tUS Infinity, extends conventional ultrasound systems with tomographic capabilities, enabling high-resolution 3D volume acquisitions of organs and structures. This technology is particularly impactful in areas such as thyroid, vascular, abdominal, and cardiac imaging, where precise volumetric measurements are crucial.

Key Technologies Utilized

• AI-Driven Image Analysis: Employs artificial intelligence to enhance image reconstruction and analysis, reducing operator dependency and improving diagnostic accuracy.

• Sensor-Based Tracking: Utilizes patented sensor technology to facilitate accurate 3D imaging during ultrasound examinations.

• Asynchronous Remote Diagnostics: Enables separation of image acquisition from analysis, allowing for remote diagnostics and increased efficiency.

Primary Markets Targeted

PIUR IMAGING primarily targets healthcare providers in Europe and the United States, focusing on markets with a high demand for advanced diagnostic imaging solutions. The company has established a significant presence in Germany, Italy, Spain, and France, with plans to expand further into the U.S. market following recent FDA clearance.

Financials and Funding

Funding History

In July 2023, PIUR IMAGING secured a €4.9 million Series A funding round led by Ascend Capital Partners, with participation from Aescuvest. The capital is allocated towards research and development, marketing and sales expansion, and strategic partnerships. This funding supports the company's efforts to enhance its product offerings and scale operations in existing and new markets, including the United States.

Pipeline Development

Product Development and Milestones

• PIUR tUS Infinity 4 for Thyroid: Launched in February 2024, this latest iteration offers rapid tomographic ultrasound acquisitions, an intuitive user interface, advanced image processing, and enhanced sensor technology. These improvements aim to set new standards in 3D ultrasound imaging for thyroid diagnostics.

• FDA Clearance: In September 2024, PIUR tUS Infinity received FDA clearance, allowing its introduction into the U.S. healthcare market. This milestone enables U.S. clinicians to utilize the technology for advanced 3D imaging, particularly in thyroid examinations.

Technological Platform and Innovation

Proprietary Technologies

• PIUR tUS Infinity: A vendor-independent tomographic 3D ultrasound solution that transforms standard ultrasound systems into advanced imaging devices. It features AI-driven software for image reconstruction and analysis, enhancing diagnostic capabilities.

Significant Scientific Methods

• AI-Based Image Reconstruction Algorithms: Utilized to generate tomographic ultrasound volumes with smart analysis tools, facilitating efficient extraction of diagnostic information.

• Sensor-Based Tracking Unit: Patented technology that enables accurate 3D imaging by tracking the position and movement of the ultrasound transducer.

Leadership Team

Executive Profiles

• Frederik Bender, CEO & Managing Director: With a strong background in healthcare innovation, Bender has been instrumental in steering PIUR IMAGING's strategic direction and growth.

• Robert Bauer, CTO & Managing Director: Bauer brings extensive experience in medical technology development, leading the company's technological advancements and product development initiatives.

• Josef Schabauer, Chief Commercial Officer (CCO): Schabauer oversees the company's commercial strategies, focusing on market expansion and partnership development.

• Branislav Holländer, Head of Software Engineering: Holländer leads the software development team, ensuring the integration of advanced AI capabilities into the company's products.

• Milad Mesri, Head of Product: Mesri is responsible for product management, focusing on aligning product development with market needs and technological trends.

Recent Leadership Appointments

• Scott Peairs, Vice President of Sales (U.S.): Appointed to lead sales operations in the United States, Peairs brings extensive experience in medical device sales and market development.

• David Cernicek, Vice President of Operations (U.S.): Cernicek oversees operational activities in the U.S., focusing on scaling the company's presence and ensuring operational excellence.

Competitor Profile

Market Insights and Dynamics

The global ultrasound imaging market is experiencing significant growth, driven by technological advancements and increasing demand for non-invasive diagnostic tools. The integration of AI and 3D imaging capabilities is a key trend, enhancing diagnostic accuracy and efficiency.

Competitor Analysis

• GE HealthCare: A leading provider of ultrasound systems, offering a range of products with advanced imaging capabilities. GE HealthCare has collaborated with PIUR IMAGING to integrate 3D thyroid imaging solutions into their LOGIQ™ consoles.

• FUJIFILM VisualSonics: Specializes in ultra-high-frequency ultrasound imaging systems. Partnered with PIUR IMAGING to bring 3D imaging technology to clinicians and researchers, enhancing the capabilities of their Vevo® MD system.

• Philips Healthcare: Offers a comprehensive portfolio of ultrasound solutions with advanced imaging features, competing in the same market segment as PIUR IMAGING.

Strategic Collaborations and Partnerships

Key Partnerships

• GE HealthCare: Collaborated to integrate PIUR's 3D thyroid imaging solution, "PIUR tUS inside," into GE's LOGIQ™ ultrasound consoles, enhancing diagnostic capabilities.

• FUJIFILM VisualSonics: Partnered to enable ultra-high-frequency 3D ultrasound imaging, combining PIUR's tUS Infinity